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More than 150,000 in Europe and 800,000 people worldwide,
die every year by suicide (WHO, 2015), accounting for 1  4%
of all annual deaths. Suicide is the second, and in some
European countries even the ﬁrst leading cause of death
amongst young people aged 15–24 years (WHO, 2015), thus
exceeding the number of accidental deaths. In Europe,
suicide rates are highest in Eastern Europe (Nock et al.,
2008). Mann et al. (2005) identiﬁed a number of effective,
national level, suicide prevention strategies.
The European parliament resolution on Mental Health 2008/
2209 (INI) adopted a series of recommendations for European
member states. It proposed areas for priority action as deﬁned
in the European Pact on Mental Health and Well-Being.
Therein, the European Parliament emphasizes the need to
implement cross-sectorial programs for the prevention of
depression and suicide across all member states.
In 2005 Ministers of Health from the WHO – European
region signed an agreement stating that suicide prevention
programs should be implemented in all European countries.
Since then, many countries have developed such programs,tal Health Center,
ach Tikva 4910002, Israel.
ac.il (G. Zalsman).however, no up-to-date, evidence-based cross-European
minimal standard for effective national suicide prevention
exists as yet. Recently, 29 suicide prevention experts from
17 European countries (The Task Force for the European
Evidence-Based Suicide Prevention Program, EESPP) per-
formed a systematic review of evidence for the effective-
ness of suicide prevention interventions that has been
published over the last decade (Zalsman et al., 2016).
During three face-to-face meetings, the EESPP group devel-
oped a consensus declaration that, based on the ﬁndings of
the systematic reviews, summarizes the minimal require-
ments for a national suicide prevention programs and of the
strategies to employ.2. Evidence-based suicide prevention
strategies
Every national suicide prevention program should rely on
evidence-based strategies.
The suicide prevention strategies that were found to have
the highest levels of evidence according to the 2016 systema-
tic review published in the Lancet Psychiatry (Zalsman et al.,
2016) may be divided into two complementary approaches,
public health policy strategies and health care strategies
(Figure 1).
This includes:
G. Zalsman et al.4201. Restriction of access to lethal means (public health).
2. Treatment of depression (pharmacotherapy and psychother-
apy( (health care).
3. Ensuring chain of care (health care).
4. School-based universal prevention (public health).
For details see Zalsman et al., (2016).3. Principles of national suicide prevention
The following principles were agreed upon:
1. Every European country should conceptualize a suicide
prevention program.
2. A suicide prevention taskforce should be established in
each country to implement the program.
3. The suicide prevention strategy should be separate from
the general mental health strategy and have indepen-
dent funding, yet be coordinated with it.
4. A scientiﬁc evaluation program should accompany every
national program.
5. Each country should monitor standardized validated data
on annual rates of attempted and completed suicides.
6. Data regarding the amount of ﬁnancial support of each
national suicide prevention taskforce should be recorded
as well as what percentage of the GDP and of the total
national budget for prevention represents.
7. The suicide prevention program, the taskforce and the
evaluation of the program should be funded by the
respective governments.Figure 1 Evidence-based strategies of suicide prevention4. National suicide prevention taskforce
We suggest that in each European country the steering
committee for a national suicide prevention program should
include at least the following participants:
1. A mental health professional with expertise in
suicidology.
2. A public health professional with expertise in suicidology.
3. A high rank government representative.
Relevant non-governmental organizations should be able
to join the taskforce in an advisory capacity.
We strongly suggest that all European countries should
initiate or reinforce current national suicide prevention
programs and taskforces, based on these agreed upon
principals, in order to decrease the burden of suicide in
Europe. Given that a single suicide incurs estimated direct
and indirect costs of approx. One million Euro to society
(CDC, 2015), thus corresponding to a yearly loss in Europe of
150 billion Euros, suicide prevention also has an signiﬁcant
economic impact and should be prioritized in all European
countries.Funding statement
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